{
  "doc_id": "Relapsing-Polychondritis",
  "doc_filename": "Relapsing-Polychondritis.pdf",
  "top_entities": [
    {
      "name": "relapsing polychondritis",
      "mention_count": 1,
      "entity_type": "disease"
    }
  ],
  "file_size_bytes": 1512,
  "file_size_human": "1.5 KB",
  "file_extension": ".pdf",
  "pdf_title": "(anonymous)",
  "pdf_author": "(anonymous)",
  "pdf_page_count": 1,
  "pdf_creation_date": "2026-01-07T22:25:17",
  "doi": null,
  "doi_url": null,
  "document_type_code": "DLA",
  "document_type_name": "Disease Landscape Analysis",
  "document_type_group": "Disease Landscape Analysis",
  "classification_confidence": 0.85,
  "title": "Relapsing Polychondritis: Clinical Overview",
  "short_description": "Clinical document describing the demographic characteristics and age of onset for relapsing polychondritis.",
  "long_description": "This clinical document provides essential demographic and epidemiological information about relapsing polychondritis, a rare inflammatory condition affecting cartilaginous structures. The document outlines that the condition shows no gender preference, affecting males and females equally, and typically manifests in middle-aged adults between the fourth and sixth decades of life. This information is fundamental for healthcare providers in understanding the patient population most commonly affected by this autoimmune disorder.",
  "document_date": "2026-01-07T22:25:17",
  "document_date_source": "pdf_metadata",
  "extraction_timestamp": "2026-02-05T02:03:06.280342"
}